Ledger.Open graph →
SEC Form D · filed September 10, 2021

Aadi Bioscience, Inc

Offering
$82.5M
Sold
$82.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Pacific Palisades, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Karin Heneberger · Pacific Palisades, CADirectorEmma Reeve · Pacific Palisades, CADirectorAnupam Dalal · Pacific Palisades, CADirectorLance Thibault · Pacific Palisades, CAExecRichard Maroun · Pacific Palisades, CADirectorCaley Castelein · Pacific Palisades, CADirectorNeil Desai · Pacific Palisades, CAExec · DirectorEric D. Mallon · Louisville, CODirectorRay Simpson · Philadelphia, PADirectorNoel Carr · Philadelphia, PAExec · DirectorAdam C. Heflin · Phoenix, AZDirectorGonzalo A. De La Melena · Phoenix, AZDirectorDonatien-Xavier Martin · Grand Duchy of Luxembourg, LuxembourgExecSteven Denbaars · Manchester, United KingdomDirectorPatricia Costello · San Mateo, CADirectorGreg Bond · Maitland, FLExec · DirectorJenna Poole · Maitland, FLDirectorAnne Dean · CHICAGO, ILDirectorJohn Hamer · Durham, NCDirectorRay Croghan · Phoenix, AZDirectorMitchell E. Goodman · IRVINE, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗